TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call
TriSalus Life Sciences, Inc. will host a conference call and webcast on May 12, 2026, to discuss its financial results for the quarter ending March 31, 2026. The company focuses on integrating novel delivery technology with standard therapies for treating solid tumors.
WESTMINSTER, Colo.–(BUSINESS WIRE)–TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to transform treatment for patients with solid tumors, announced today that it will host a conference call and webcast on Tuesday, May 12, 2026 at 4:30 PM eastern time to discuss its financial results for the quarter ended March 31, 2026. A press release detailing the